BRPI0915527A2 - pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos - Google Patents

pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos

Info

Publication number: BRPI0915527A2
Authority: BR; Brazil
Prior art keywords: pepitides; exosomes; methods; same; pharmaceutical composition
Prior art date: 2008-06-11

Application number

BRPI0915527A

Other languages

English (en)

Inventor

Ryuji Ohsawa

Sachiko Yoshimura

Takukya Tsunoda

Tomohisa Watanabe

Original Assignee

Oncotherapy Science Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-11

Filing date

2009-06-10

Publication date

2016-01-26

2009-06-10 Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc

2016-01-26 Publication of BRPI0915527A2 publication Critical patent/BRPI0915527A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4722—G-proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C07K14/4706—Guanosine triphosphatase activating protein, GAP
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Epidemiology (AREA)
Oncology (AREA)
Microbiology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BRPI0915527A 2008-06-11 2009-06-10 pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos BRPI0915527A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6053808P	2008-06-11	2008-06-11
PCT/JP2009/002613 WO2009150835A1 (en)	2008-06-11	2009-06-10	Iqgap3 epitope peptides and vaccines containing the same

Publications (1)

Publication Number	Publication Date
BRPI0915527A2 true BRPI0915527A2 (pt)	2016-01-26

Family

ID=41416549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0915527A BRPI0915527A2 (pt)	2008-06-11	2009-06-10	pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos

Country Status (13)

Country	Link
US (1)	US20110200626A1 (pt)
EP (1)	EP2303909A4 (pt)
JP (1)	JP2011523937A (pt)
KR (1)	KR20110036903A (pt)
CN (1)	CN102119169A (pt)
AU (1)	AU2009258788A1 (pt)
BR (1)	BRPI0915527A2 (pt)
CA (1)	CA2727485A1 (pt)
IL (1)	IL209869A0 (pt)
MX (1)	MX2010013680A (pt)
RU (1)	RU2010154081A (pt)
TW (1)	TW201000115A (pt)
WO (1)	WO2009150835A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI580431B (zh)	2008-08-19	2017-05-01	腫瘤療法科學股份有限公司	Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201134480A (en) *	2010-04-08	2011-10-16	Oncotherapy Science Inc	CLUAP1 peptides and vaccines including the same
CN109734777B (zh)	2015-08-28	2023-04-07	伊玛提克斯生物技术有限公司	用于各种癌症免疫治疗的新型肽、肽组合物和支架
GB201515321D0 (en) *	2015-08-28	2015-10-14	Immatics Biotechnologies Gmbh	Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers
GB201520550D0 (en)	2015-11-23	2016-01-06	Immunocore Ltd & Adaptimmune Ltd	Peptides
GB201520542D0 (en) *	2015-11-23	2016-01-06	Immunocore Ltd & Adaptimmune Ltd	Peptides
GB201520568D0 (en)	2015-11-23	2016-01-06	Immunocore Ltd	Peptides
US11358087B2 (en)	2017-04-26	2022-06-14	Gvs Filtration Inc.	Multiple bead air filter seal
CN112521455B (zh) *	2020-12-08	2022-09-02	长春理工大学	一种检测膀胱癌抗原蛋白特异性的多肽及其应用
CN118930633A (zh) *	2023-05-12	2024-11-12	中国科学院深圳先进技术研究院	肿瘤相关抗原表位肽及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001238347A1 (en) *	2000-02-28	2001-09-12	Hyseq, Inc.	Novel nucleic acids and polypeptides
DE102004026135A1 (de) *	2004-05-25	2006-01-05	Immatics Biotechnologies Gmbh	An MHC-Moleküle bindende Tumor-assoziierte Peptide
EP1856278A2 (en) *	2005-02-10	2007-11-21	Oncotherapy Science, Inc.	Method of diagnosing bladder cancer
CN101283106A (zh) *	2005-07-27	2008-10-08	肿瘤疗法科学股份有限公司	小细胞肺癌的诊断方法
CN101273144B (zh) *	2005-07-27	2011-12-28	肿瘤疗法科学股份有限公司	诊断食道癌的方法

2009
- 2009-06-09 TW TW098119196A patent/TW201000115A/zh unknown
- 2009-06-10 MX MX2010013680A patent/MX2010013680A/es not_active Application Discontinuation
- 2009-06-10 KR KR1020117000473A patent/KR20110036903A/ko not_active Withdrawn
- 2009-06-10 CA CA2727485A patent/CA2727485A1/en not_active Abandoned
- 2009-06-10 US US12/997,517 patent/US20110200626A1/en not_active Abandoned
- 2009-06-10 CN CN2009801312154A patent/CN102119169A/zh active Pending
- 2009-06-10 JP JP2010548687A patent/JP2011523937A/ja not_active Withdrawn
- 2009-06-10 AU AU2009258788A patent/AU2009258788A1/en not_active Abandoned
- 2009-06-10 BR BRPI0915527A patent/BRPI0915527A2/pt not_active IP Right Cessation
- 2009-06-10 WO PCT/JP2009/002613 patent/WO2009150835A1/en active Application Filing
- 2009-06-10 RU RU2010154081/04A patent/RU2010154081A/ru not_active Application Discontinuation
- 2009-06-10 EP EP09762266A patent/EP2303909A4/en not_active Withdrawn
2010
- 2010-12-09 IL IL209869A patent/IL209869A0/en unknown

Also Published As

Publication number	Publication date
CN102119169A (zh)	2011-07-06
KR20110036903A (ko)	2011-04-12
RU2010154081A (ru)	2012-07-20
EP2303909A1 (en)	2011-04-06
IL209869A0 (en)	2011-02-28
MX2010013680A (es)	2011-02-23
TW201000115A (en)	2010-01-01
WO2009150835A1 (en)	2009-12-17
AU2009258788A1 (en)	2009-12-17
EP2303909A4 (en)	2012-10-31
CA2727485A1 (en)	2009-12-17
US20110200626A1 (en)	2011-08-18
JP2011523937A (ja)	2011-08-25

Publication	Publication Date	Title
BRPI0915527A2 (pt)	2016-01-26	pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BRPI0910503A2 (pt)	2015-09-29	compostos, composições farmacêuticas e respectivos usos.
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BRPI1009372A2 (pt)	2016-05-31	compostos, composição farmacêutica e respectivos usos
BRPI1008709A2 (pt)	2016-03-08	composições e usos das mesmas.
BRPI1009324A2 (pt)	2015-11-24	compostos e/ou farmaceuticamente aceitáveis dos mesmos, composição farmacêutica e respectivos usos
BRPI0906962A2 (pt)	2015-07-14	Composto, e, composição farmacêutica
BRPI0906556A2 (pt)	2015-07-07	Composto, e, composição farmacêutica
BR112013015592A2 (pt)	2016-07-12	dericados de biciclo-[3.2.1]-octilamida e usos dos mesmos
BRPI0918502A2 (pt)	2015-12-01	aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BRPI0918652A2 (pt)	2015-08-25	Composições farmacêuticas e métodos de libração relacionadas.
HUE053357T2 (hu)	2021-06-28	Gyógyszerészeti készítmény és annak beadásai
BRPI0922233A2 (pt)	2018-05-29	compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0912717A2 (pt)	2014-12-23	Composição farmacêutica, e, uso de 5-azacitidina
BRPI0822337A2 (pt)	2015-06-16	Folatos, composições e usos dos mesmos
BR112012022879A2 (pt)	2016-06-14	composto, composição farmacêutica, uso do composto e método de tratamento
BR112012031226A2 (pt)	2018-03-06	composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BRPI0914343A2 (pt)	2016-07-26	composição, produto, uso da composição e método
BRPI0907453A2 (pt)	2015-07-14	Compostos, uso e preparação dos mesmos
FI20086253L (fi)	2010-07-01	Sieniendoglukanaasit, niiden valmistus ja käyttö
FI20086250L (fi)	2010-07-01	Sieniendoglukanaasit, niiden valmistus ja käyttö
BRPI0917681A2 (pt)	2015-08-04	Composto, e, composição farmacêutica
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
BR112012003800A2 (pt)	2016-11-22	composição, peptídeo, e formulação farmacêutica.
IT1403847B1 (it)	2013-11-08	Composizioni farmaceutiche comprendenti rifaximina e loro uso.

Legal Events

Date	Code	Title	Description
2016-06-28	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 5A,6A E 7A ANUIDADES
2016-10-18	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2373 DE 28-06-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2018-03-27	B15K	Others concerning applications: alteration of classification	Ipc: C07K 14/47 (2006.01), A61K 39/00 (2006.01), C07K 7